INDICATIONS:
It is indicated in the treatment of
Primary biliary cirrhosis (PBC) and for the dissolution of radiolucent, cholesterol-rich gall-stones in patients with a functioning gall bladder.
Cholesterol stones coated with calcium or stones composed of bile pigments are not dissolved by ursodeoxycholic acid.
Pediatric population: Hepatobiliary disorders associated with cystic fibrosis in children aged 6 to 18 years.